Airain ltd - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
Airain ltd ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2017$325,000
-63.5%
38,866
-61.0%
0.01%
-68.2%
Q1 2017$891,000
+11.7%
99,698
+9.8%
0.04%
-31.2%
Q4 2016$798,000
+144.0%
90,781
-1.1%
0.06%
+236.8%
Q2 2016$327,000
-17.2%
91,754
-31.4%
0.02%
-29.6%
Q1 2016$395,000
-55.4%
133,841
-36.2%
0.03%
-55.7%
Q4 2015$885,000
-16.4%
209,676
+42.8%
0.06%
+3.4%
Q2 2015$1,059,000
+129.7%
146,834
+135.0%
0.06%
+110.7%
Q1 2015$461,000
-51.2%
62,493
-68.7%
0.03%
-63.6%
Q4 2014$945,000199,7610.08%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders